Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing
Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity
Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19